Integral Diagnostics Limited
ITGDF
$1.00
-$1.06-51.41%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 2.95M | 3.32M | 3.73M | -17.90M | -39.62M |
Total Depreciation and Amortization | 32.60M | 30.14M | 27.85M | 27.63M | 27.23M |
Total Amortization of Deferred Charges | 4.62M | 4.19M | 3.80M | 3.80M | 3.80M |
Total Other Non-Cash Items | -435.90K | 4.89M | 10.21M | 29.78M | 49.46M |
Change in Net Operating Assets | 7.62M | 5.08M | 2.62M | 2.62M | 2.62M |
Cash from Operations | 47.37M | 47.62M | 48.19M | 45.92M | 43.48M |
Capital Expenditure | -38.61M | -32.06M | -25.72M | -20.81M | -15.66M |
Sale of Property, Plant, and Equipment | 206.90K | 206.90K | 206.90K | 104.90K | -- |
Cash Acquisitions | 9.86M | 9.78M | 9.71M | 3.61M | -2.63M |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -13.53M | -13.53M | -13.53M | -6.86M | -- |
Cash from Investing | -42.07M | -35.60M | -29.34M | -23.95M | -18.29M |
Total Debt Issued | 343.38M | 333.38M | 323.38M | 161.69M | -- |
Total Debt Repaid | -326.65M | -325.90M | -325.14M | -171.25M | -17.35M |
Issuance of Common Stock | -- | -- | -- | 145.50K | 291.00K |
Repurchase of Common Stock | -- | -145.50K | -291.00K | -291.00K | -291.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -10.00M | -8.97M | -7.99M | -7.99M | -7.93M |
Other Financing Activities | -563.00K | -641.00K | -719.00K | -359.50K | 0.00 |
Cash from Financing | 425.20K | -4.69M | -9.79M | -14.54M | -19.31M |
Foreign Exchange rate Adjustments | 109.50K | -118.20K | -343.90K | -245.20K | -145.40K |
Miscellaneous Cash Flow Adjustments | -- | -300.00 | -600.00 | -300.00 | 0.00 |
Net Change in Cash | 5.83M | 7.21M | 8.71M | 7.18M | 5.73M |